J B Opalinska1, A Kalota, Lida K Gifford
1Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Novel oxetane (OXE) modified antisense oligodeoxyribonucleotides (ODNs) demonstrate potent gene silencing. Rationally targeted OXE ODNs show enhanced efficiency for potential therapeutic applications.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: